Transcode Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -13 | -51 | 284 | -127 |
EBITDA | -4,263 | -12,034 | -21 | -2,183 |
EBIT | -4,276 | -12,085 | -148 | -2,310 |
Net Income | -4,276 | -12,085 | -2,351 | -2,321 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,287,949 | -3,097 | -3,146 | -3,925 |
Cash | 7,374 | 11,569 | 5,811 | 1,875 |
Basic Shares | 833 | 172 | 356 | 356 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -516 | -98 | -42 | |
EBITDA | -16,193 | -17,973 | -17,466 | -6,108 |
EBIT | -16,728 | -18,490 | -17,564 | -6,151 |
Net Income | -16,754 | -18,546 | -35,129 | -6,938 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -13,357 | -18,110 | -15,863 | -5,521 |
Cash | 5,811 | 2,767 | 4,968 | 20,825 |
Basic Shares | 356 | 5 | 16 | 16 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$5.13 |
2025-03-31 | -$1,286.15 |
2024-12-31 | -$1,286.14 |
2024-09-30 | -$147.84 |
